Fate Therapeutics(FATE) - 2019 Q1 - Earnings Call Transcript

Fate Therapeutics, Inc. (NASDAQ:FATE) Q1 2019 Results Earnings Conference Call May 7, 2019 4:30 PM ET Company Participants Scott Wolchko - President and CEO Dr. Dan Shoemaker - Chief Scientific Officer Conference Call Participants David Nierengarten - Wedbush Edward Tenthoff - Piper Jaffray Biren Amin - Jefferies Daina Graybosch - SVB Leerink Nick Abbott - Wells Fargo Operator Welcome to the Fate Therapeutics First Quarter 2019 Financial Results Conference Call. At this time, all participants are in a liste ...